Growth Metrics

Aura Biosciences (AURA) Change in Accured Expenses (2020 - 2026)

Aura Biosciences filings provide 7 years of Change in Accured Expenses readings, the most recent being -$2.7 million for Q1 2026.

  • Quarterly Change in Accured Expenses fell 10.91% to -$2.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.9 million through Mar 2026, up 93.34% year-over-year, with the annual reading at $4.1 million for FY2025, 161.95% up from the prior year.
  • Change in Accured Expenses hit -$2.7 million in Q1 2026 for Aura Biosciences, down from -$124000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $3.4 million in Q2 2025 and bottomed at -$2.9 million in Q1 2024.
  • Average Change in Accured Expenses over 5 years is $382764.7, with a median of $1.0 million recorded in 2023.
  • The largest annual shift saw Change in Accured Expenses soared 315.98% in 2023 before it tumbled 629.41% in 2025.
  • Aura Biosciences' Change in Accured Expenses stood at -$701000.0 in 2022, then soared by 315.98% to $1.5 million in 2023, then plummeted by 101.12% to -$17000.0 in 2024, then tumbled by 629.41% to -$124000.0 in 2025, then tumbled by 2113.71% to -$2.7 million in 2026.
  • Per Business Quant, the three most recent readings for AURA's Change in Accured Expenses are -$2.7 million (Q1 2026), -$124000.0 (Q4 2025), and $3.3 million (Q3 2025).